Zev Schuman-Olivier, MD

Zev Schuman-Olivier, MD is the Center Director of the CHA Center for Mindfulness and Compassion, and Director of the Mindful Mental Health Service at CHA. He is Director of Addiction Research at CHA and previously served for 5 years as Medical Director for Addiction Services and Director of Addiction Residency Education. Dr. Schuman-Olivier is Assistant Professor in the Department of Psychiatry at Harvard Medical School and a Faculty Affiliate at the Center for Technology and Behavioral Health at Dartmouth. As a board-certified addiction psychiatrist, he has been involved with research and clinical care of patients with addiction, mental illness, and chronic pain both in mental health and primary care settings.

He is a founding member of the Mindfulness Research Collaborative and participates in the NIH Science of Behavior Change Initiative and HEAL Initiatives (https://heal.nih.gov/). He was the principal investigator of the MINDFUL-PC project, which led the way in integrating mindfulness into the patient-centered medical home. Prior to his psychiatry residency, he implemented the first federally-funded, randomized controlled trial of a mindfulness-oriented intervention for addictive disorders, and he is now principal investigator of the MINDFUL-OBOT trial, which is the first study to investigate the effects of mindfulness training in primary care office-based opioid treatment.

He is Director of the Clinical Core for the NCCIH program project grant on synergistic approaches to chronic pain treatment. Dr. Schuman-Olivier also presents locally, regionally and nationally on mindfulness for behavior change and in addictions treatment, and trains residents and peers on these topics.